electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th

electroCore, Inc. (NASDAQ: ECOR) will report its financial results for the second quarter ending June 30, 2021, on August 5, 2021, after market close.

Rhea-AI Summary

electroCore, Inc. (NASDAQ: ECOR) will report its financial results for the second quarter ending June 30, 2021, on August 5, 2021, after market close. A conference call and webcast for discussion will take place at 4:30 PM ET on the same day. electroCore focuses on bioelectronic medicine, utilizing a non-invasive vagus nerve stimulation therapy platform aimed at treating conditions like migraines and cluster headaches. The company emphasizes its commitment to enhancing patient outcomes through this innovative treatment approach.

Argus Session date unavailable

-2.86% session move Open Argus

Details

News Market Reaction – ECOR

The recorded move for ECOR in the trading session of this news was -2.86%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKAWAY, NJ, July 22, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second quarter ended June 30, 2021 after the close of the market on Thursday, August 5, 2021. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.

Thursday, August 5, 2021, 4:30pm Eastern Time
Domestic: 888-506-0062
International: 973-528-0011
Conference ID: 748491
Webcast: electroCore 2Q21 Business Update Webcast

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will electroCore announce its second-quarter financial results?

electroCore will announce its second-quarter financial results on August 5, 2021, after market close.

What time is the conference call for electroCore's financial results?

The conference call for electroCore's financial results will take place at 4:30 PM ET on August 5, 2021.

What conditions does electroCore's therapy focus on treating?

electroCore's therapy primarily focuses on treating migraines and cluster headaches.

How can I access the webcast for electroCore's business update?

You can access the webcast for electroCore's business update through their official website on August 5, 2021.